ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Opinions
Top ASX shares to buy in FY24
Growth Shares
Morgans says these are the best ASX growth shares to buy in July
Blue Chip Shares
Analysts say these ASX 200 blue chip shares are buys in July
How to invest
$20,000 invested in these ASX shares 10 years ago is worth how much today?
Share Market News
Here are the top 10 ASX 200 shares today
Healthcare Shares
Morgans names the best ASX healthcare shares to buy
Growth Shares
3 stellar ASX 200 growth shares brokers say are buys
How to invest
How I'd invest $400 per month to target a $4,000 annual passive income
Broker Notes
Brokers name 3 ASX 200 shares to buy this week
Growth Shares
Brokers say these excellent ASX growth shares are top buys
Broker Notes
2 ASX 200 healthcare shares to grab for 'attractive outlook'
Broker Notes
Leading brokers name 3 ASX shares to buy today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
